Healthcare

Autotransfusion Devices Market 2024 – Size, Industry Growth Rate, Top Trends, Major Players And Forecast To 2033 | Becton Dickinson And Company, Medtronic PLC, LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co KGaA

The Autotransfusion Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Autotransfusion Devices Market:
https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report

According to The Business Research Company’s Autotransfusion Devices Global Market Report 2024, The autotransfusion devices market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, efforts to reduce blood transfusion costs.

The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing geriatric population, expansion of ambulatory surgical centers, focus on blood conservation in obstetrics, adoption in developing healthcare markets. Major trends in the forecast period include technological advancements in blood processing, integration of advanced sensors, customization for different procedures, single-donor closed-loop systems, miniaturization of devices.

Increasing prevalence of cardiovascular diseases is expected to propel the growth of the autotransfusion device market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels. Autotransfusion devices contribute to the trend of minimizing the use of allogeneic blood transfusions. Allogeneic transfusions involve donated blood from external sources, and autotransfusion allows for the reinfusion of the patient’s own blood, reducing the risk of transfusion reactions and complications associated with donor blood. For instance, according to the Heart Disease and Stroke Statistics-2022 Update report by American Heart Association, a US-based non-profit organization, cardiovascular diseases (CVDs) remain the leading cause of death globally, taking an estimated 17.9 million lives each year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the autotransfusion device market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp

The autotransfusion devices market covered in this report is segmented –

1) Autotransfusion Devices Market By Product Type: Autotransfusion Systems, Consumables And Accessories
2) Autotransfusion Devices Market By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) Autotransfusion Devices Market By End-Use: Hospitals, Specialty Clinics, Other End Users

Top Major Players

Becton Dickinson And Company

Medtronic PLC

LivaNova PLC

Haemonetics Corporation

Fresenius SE & Co KGaA

Major companies operating in the autotransfusion devices market are undergoing strategic partnerships to enhance management of controlled substances. Collaboration allows companies to combine their expertise and resources for the development of advanced technologies and innovative solutions in autotransfusion devices. For instance, in November 2021, Omnicell, a US-based healthcare company and Fresenius Kabi, a Germany-based pharmaceutical company joined forces to improve controlled substance management in healthcare settings. Their collaboration aims to streamline the management of autotransfusion devices and other controlled substances, ensuring patient safety and regulatory compliance.

The autotransfusion devices market report table of contents includes:

1. Executive Summary

2. Autotransfusion Devices Market Characteristics

3. Autotransfusion Devices Market Trends And Strategies

4. Autotransfusion Devices Market – Macro Economic Scenario

5. Global Autotransfusion Devices Market Size and Growth

……

31. Global Autotransfusion Devices Market Competitive Benchmarking

32. Global Autotransfusion Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Autotransfusion Devices Market

34. Autotransfusion Devices Market Future Outlook and Potential Analysis

35. Appendix